Arrowhead Pharmaceuticals, Inc.

LOS ANGELES CAPITAL MANAGEMENT LLC ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

18,686

Value ($000)

791

Weight

0.0%

2019 Q4 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	791	0.0%	18,686	12/31/2025
2025 Q3	10/20/2025	644	0.0%	18,686	9/30/2025
2025 Q2	8/7/2025	916	0.0%	57,948	6/30/2025
2023 Q3	11/6/2023	326	0.0%	12,132	9/30/2023
2023 Q2	8/3/2023	535	0.0%	15,000	6/30/2023
2023 Q1	5/4/2023	216	0.0%	8,510	3/31/2023
2022 Q4	2/6/2023	528	0.0%	13,009	12/31/2022
2022 Q3	11/2/2022	466	0.0%	14,109	9/30/2022
2022 Q2	8/5/2022	447	0.0%	12,708	6/30/2022
2022 Q1	5/6/2022	407	0.0%	8,847	3/31/2022
2021 Q4	2/3/2022	560	0.0%	8,453	12/31/2021
2021 Q3	11/8/2021	520	0.0%	8,323	9/30/2021
2021 Q2	8/5/2021	754	0.0%	9,104	6/30/2021
2021 Q1	5/5/2021	1,375	0.0%	20,731	3/31/2021
2020 Q4	3/10/2021	3,104	0.0%	40,456	12/31/2020
2020 Q3	11/2/2020	1,945	0.0%	45,166	9/30/2020
2020 Q2	8/5/2020	4,880	0.0%	112,993	6/30/2020
2020 Q1	5/4/2020	3,213	0.0%	111,670	3/31/2020
2019 Q4	2/7/2020	6,557	0.0%	103,370	12/31/2019